按女性生殖器官解剖部位 ,分别介绍免疫组化在病理诊断、鉴别诊断及预后评估等方面的应用价值 ,重点推荐近年涌现的新抗体及现有抗体的新用途。例如用ER、PR判定肿瘤是否属雌激素依赖性肿瘤 ,以指导临床治疗 ;p5 3过表达率与肿瘤患者生存期呈负相关 ,EGFR及c erbB 2的表达率与生存率亦呈负相关等。 According to anatomical sites of female genital organs, the application value of immunohistochemistry in pathological diagnosis, differential diagnosis and prognosis evaluation are respectively introduced, and the new antibodies emerging in recent years and the new use of existing antibodies are mainly recommended. For example, with ER, PR to determine whether the tumor is estrogen-dependent tumors, to guide clinical treatment; p5 3 overexpression rate and tumor survival was negatively correlated, EGFR and c erbB 2 expression rate and survival rate was also negatively correlated .